venetoclax
aptose,Roche,Abbvie
[]
rbc cm on $apto
updates from eha 2023: supportive data cut on 77 patients dosed, aptivate expansion brisk as accelerated path in play post-eop1; intrigue on in vitro tus/ven synergies 